Healthcare Services US

US Prediabetes Management Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

US Prediabetes Management Market Industry Trends and Forecast to 2034: Segmented by (Approach, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.02 Bn Placeholder estimate
Estimate 2025 $2.17 Bn 43.5% of the global market
Projected 2034 $4.10 Bn 88.5% Adds $1.92 Bn over 9 forecast years
CAGR 2025–2034 7.3% Faster than 54% of 107 Healthcare Services markets here
Key players 5
  • US is 43.53% of the global market.
  • In North America, the largest is US (this report) at $2.17 Bn.
  • Fastest growing: Canada at 9.3% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.92 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Prediabetes Management Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.02 Bn — —
2025 (base) $2.17 Bn +$147.8 Mn —
2026 (forecast) $2.33 Bn +$158.6 Mn +7.3%
2027 (forecast) $2.50 Bn +$170.2 Mn +15.1%
2028 (forecast) $2.68 Bn +$182.6 Mn +23.5%
2029 (forecast) $2.88 Bn +$195.9 Mn +32.6%
2030 (forecast) $3.09 Bn +$210.2 Mn +42.2%
2031 (forecast) $3.32 Bn +$225.6 Mn +52.6%
2032 (forecast) $3.56 Bn +$242.0 Mn +63.8%
2033 (forecast) $3.82 Bn +$259.7 Mn +75.7%
2034 (forecast) $4.10 Bn +$278.6 Mn +88.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Prediabetes Management Market Analysis at a glance
Market size, 2025$2.17 Bn placeholder estimate
Forecast, 2034$4.10 Bn placeholder estimate
Growth (CAGR), 2025–20347.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApproach, setting and end user (see all)
Key playersOmada Health, Abbott Laboratories, Roche Diagnostics, Merck KGaA, Teladoc Health (see all)
Active clinical trials153 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Prediabetes Management Market Analysis Executive Summary

Prediabetes management covers tests, programs, medicines and digital tools that help people with raised blood sugar avoid type 2 diabetes.

Key segments of the prediabetes Management market include approach (Lifestyle Programs, Medication and Digital Coaching) and setting (Primary Care, Workplace Programs and Home).

Bar chart: US Prediabetes Management market size, 2024–2034, placeholder estimates. $2.02 Bn in 2024, $2.17 Bn in 2025 and $4.10 Bn in 2034, 7.3% CAGR.
US Prediabetes Management market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Prediabetes Management Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the prediabetes Management market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the prediabetes Management market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the prediabetes Management market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Prediabetes Management Market in US

The prediabetes Management market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Prediabetes Management Market in US

Prediabetes Management in the US: payment and research

Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[1] ClinicalTrials.gov lists 153 studies on Prediabetes Management that are recruiting, active or about to start in the US.⁠[2] Diabetes (adults): 12.5% of adults in 2022, the latest WHO figure for the US.⁠[3]

[1] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[2] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[3] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how prediabetes Management services are delivered and paid for in US. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Prediabetes Management right now, from free public sources.

Clinical trials

153 active trials in the US

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Signos 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Prediabetes Management in context

The US compared

  • Diabetes (adults, WHO): 12.5% of adults (2022). World: 14.1% of adults (2022).[1]
  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[2]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[3]

[1] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 18 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

Free data on this topic

Inside the US

Quick answers

Frequently asked questions

How big is the Prediabetes Management market in the US?
Placeholder estimate: about $2.17 Bn in 2025, rising to about $4.10 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Prediabetes Management market in the US growing?
Placeholder estimate: about 7.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Prediabetes Management market report cover?
The report splits the market by approach (Lifestyle Programs, Medication, Digital Coaching, Screening and Testing), setting (Primary Care, Workplace Programs, Home) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Prediabetes Management market?
Key players include Omada Health, Abbott Laboratories, Roche Diagnostics, Merck KGaA and Teladoc Health.
What is driving the Prediabetes Management market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the prediabetes Management market.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How many clinical trials on Prediabetes Management are running in the US?
153 studies are recruiting, active or about to start in the US, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
What does WHO report for the US?
Diabetes (adults): 12.5% of adults in 2022, the latest WHO figure. Source: WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 15 Nov 2026.
How many people in the US are 65 or older?
18.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 18 Nov 2026.
How much research is published on Prediabetes Management?
PubMed lists 57 papers on Prediabetes Management added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in US

See all

Related on diabetes and obesity

See the topic